The role of apelin in central cardiovascular regulation in rats with post-infarct heart failure maintained on a normal fat or high fat diet

Clinical and Experimental Pharmacology and Physiology

Volumn 43, Issue 10, 2016, Pages 983-994

  Czarzasta, Katarzyna ^a   Cudnoch Jedrzejewska, Agnieszka ^a   Szczepanska Sadowska, Ewa ^a   Fus, Lukasz ^a   Puchalska, Liana ^a   Gondek, Agata ^a   Dobruch, Jakub ^b   Gomolka, Ryszard ^c   Wrzesien, Robert ^a   Zera, Tymoteusz ^a   Gornicka, Barbara ^a   Kuch, Marek ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

^c WARSAW UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

apelin; APJ receptor; blood pressure; high fat diet; post infarct heart failure

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; APELIN; APELIN 13; APELIN RECEPTOR; MESSENGER RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; EPIDIDYMIS FAT; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART RATE; HYPOTHALAMUS; LIPID DIET; MALE; MEAN ARTERIAL PRESSURE; MEDULLA OBLONGATA; NONHUMAN; PROTEIN EXPRESSION; RAT; RETROPERITONEAL FAT; VENOUS BLOOD;

EID: 84985036856     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/1440-1681.12617     Document Type: Article

References (60)

1. Hosoya M, Kawamata Y, Fukusumi S, et al. Molecular and functional characteristics of APJ. Tissue distribution of mRNA and interaction with the endogenous ligand apelin. J Biol Chem. 2000;275:21061–21067.
2. Kawamata Y, Habata Y, Fukusumi S, et al. Molecular properties of apelin: tissue distribution and receptor binding. Biochim Biophys Acta. 2001;1538:162–171.
3. Reaux A, Gallatz K, Palkovits M, et al. Distribution of apelin-synthesizing neurons in the adult rat brain. Neuroscience. 2002;113:653–662.
4. O'Carroll AM, Lolait SJ, Harris LE, Pope GR. The apelin receptor APJ: journey from an orphan to a multifaceted regulator of homeostasis. J Endocrinol. 2013;219:R13–R25.
5. Boucher J, Masri B, Daviaud D, et al. Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology. 2005;146:1764–1771.
6. Wei L, Hou X, Tatemoto K. Regulation of apelin mRNA expression by insulin and glucocorticoids in mouse 3T3-L1 adipocytes. Regul Pept. 2005;132:27–32.
7. Daviaud D, Boucher J, Gesta S, et al. TNF alpha up-regulates apelin expression in human and mouse adipose tissue. FASEB J. 2006;20:1528–1530.
8. Castan-Laurel I, Dray C, Attané C, Duparc T, Knauf C, Valet P. Apelin, diabetes, and obesity. Endocrine. 2011;40:1–9.
9. De Mota N, Lenkei Z, Llorens-Cortès C. Cloning, pharmacological characterization and brain distribution of the rat apelin receptor. Neuroendocrinology. 2000;72:400–407.
10. O'Carroll AM, Selby TL, Palkovits M, Lolait SJ. Distribution of mRNA encoding B78/apj, the rat homologue of the human APJ receptor, and its endogenous ligand apelin in brain and peripheral tissues. Biochim Biophys Acta. 2000;1492:72–80.
11. Castan-Laurell I, Vítkova M, Daviaud D, et al. Effect of hypocaloric diet-induced weight loss in obese women on plasma apelin and adipose tissue expression of apelin and APJ. Eur J Endocrinol. 2008;158:905–910.
12. Valle A, Hoggard N, Adams AC, Roca P, Speakman JR. Chronic central administration of apelin-13 over 10 days increases food intake, body weight, locomotor activity and body temperature in C57BL/6 mice. J Neuroendocrinol. 2008;20:79–84.
13. García-Díaz D, Campión J, Milagro FI, Martínez JA. Adiposity dependent apelin gene expression: relationships with oxidative and inflammation markers. Mol Cell Biochem. 2007;305:87–94.
14. Szokodi I, Tavi P, Földes G, et al. Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility. Circ Res. 2002;91:434–440.
15. Berry MF, Pirolli TJ, Jayasankar V, et al. Apelin has in vivo inotropic effects on normal and failing hearts. Circulation 2004;11(Suppl 1):II187–II193.
16. Farkasfalvi K, Stagg MA, Coppen SR, et al. Direct effects of apelin on cardiomyocyte contractility and electrophysiology. Biochem Biophys Res Commun. 2007;357:889–895.
17. Chandrasekaran B, Dar O, McDonagh T. The role of apelin in cardiovascular function and heart failure. Eur J Heart Fail. 2008;10:725–732.
18. Czarzasta K, Cudnoch-Jedrzejewska A. The role of the apelinergic and vasopressinergic systems in the regulation of the cardiovascular system and the pathogenesis of cardiovascular disease. Kardiol Pol. 2014;72:122–125.
19. Yu XH, Tang ZB, Liu LJ, et al. Apelin and its receptor APJ in cardiovascular diseases. Clin Chim Acta. 2014;428:1–8.
20. Wu D, He L, Chen L. Apelin/APJ system: a promising therapy target for hypertension. Mol Biol Rep. 2014;41:6691–6703.
21. Clarke KJ, Whitaker KW, Reyes TM. Diminished metabolic responses to centrally-administered apelin-13 in diet-induced obese rats fed a high-fat diet. J Neuroendocrinol. 2009;21:83–89.
22. Fernández-Galilea M, Pérez-Matute P, Prieto-Hontoria P, Martínez JA, Moreno-Aliaga MJ. Effects of lipoic acid on apelin in 3T3-L1 adipocytes and in high-fat fed rats. J Physiol Biochem. 2011;67:479–486.
23. Reaux A, De Mota N, Skultetyova I, et al. Physiological role of a novel neuropeptide, apelin, and its receptor in the rat brain. J Neurochem. 2001;77:1085–1096.
24. Dai L, Smith PM, Kuksis M, Ferguson AV. Apelin acts in the Subfornical Organ to influence neuronal excitability and cardiovascular function. J Physiol. 2013;591:3421–3432.
25. Kagiyama S, Fukuhara M, Matsumura K, Lin Y, Fujii K, Iida M. Central and peripheral cardiovascular action of apelin in conscious rats. Regul Pept. 2005;125:55–59.
26. Cudnoch-Jedrzejewska A, Gomolka R, Szczepanska-Sadowska E, et al. High-fat diet and chronic stress reduce central pressor and tachycardic effects of apelin in Sprague-Dawley rats. Clin Exp Pharmacol Physiol 2015;42:52–62.
27. Seyedabadi M, Goodchild AK, Pilowsky PM. Site-specific effects of apelin-13 in the rat medulla oblongata on arterial pressure and respiration. Auton Neurosci. 2002;101:32–38.
28. Kuba K, Zhang L, Imai Y, et al. Impaired heart contractility in Apelin gene-deficient mice associated with aging and pressure overload. Circ Res. 2007;101:e32–e42.
29. Sheikh AY, Chun HJ, Glassford AJ, et al. In vivo genetic profiling and cellular localization of apelin reveals a hypoxia-sensitive, endothelial-centered pathway activated in ischemic heart failure. Am J Physiol Heart Circ Physiol. 2008;294:H88–H98.
30. Pchejetski D, Foussal C, Alfarano C, et al. Apelin prevents cardiac fibroblast activation and collagen production through inhibition of sphingosine kinase 1. Eur Heart J. 2012;33:2360–2369.
31. Iwanaga Y, Kihara Y, Takenaka H, Kita T. Down-regulation of cardiac apelin system in hypertrophied and failing hearts: possible role of angiotensin II-angiotensin type 1 receptor system. J Mol Cell Cardiol. 2006;41:798–806.
32. Duparc T, Colom A, Cani PD, et al. Central apelin controls glucose homeostasis via a nitric oxide-dependent pathway in mice. Antioxid Redox Signal. 2011;15:1477–1496.
33. Japp AG, Cruden NL, Amer DA, et al. Vascular Effects of Apelin in vivo in man. J Am Coll Cardiol. 2008;52:908–913.
34. Japp AG, Cruden NL, Barnes G, et al. Acute cardiovascular effects of apelin in humans: potential role in patients with chronic heart failure. Circulation. 2010;121:1818–1827.
35. Jia YX, Pan CS, Zhang J, et al. Apelin protects myocardial injury induced by isoproterenol in rats. Regul Pept. 2006;133:147–154.
36. Chen MM, Ashley EA, Deng DX, et al. Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction. Circulation. 2003;108:1432–1439.
37. Miettinen KH, Magga J, Vuolteenaho O, et al. Utility of plasma apelin and other indices of cardiac dysfunction in the clinical assessment of patients with dilated cardiomyopathy. Regul Pept. 2007;140:178–184.
38. Glassford AJ, Yue P, Sheikh AY, et al. HIF-1 regulates hypoxia- and insulin-induced expression of apelin in adipocytes. Am J Physiol Endocrinol Metab. 2007;293:E1590–E1596.
39. Ronkainen VP, Ronkainen JJ, Hänninen SL, et al. Hypoxia inducible factor regulates the cardiac expression and secretion of apelin. FASEB J. 2007;21:1821–1830.
40. Eyries M, Siegfried G, Ciumas M, et al. Hypoxia-induced apelin expression regulates endothelial cell proliferation and regenerative angiogenesis. Circ Res. 2008;103:432–440.
41. Hampl R, Bičíková M, Sosvorová L. Hormones and the blood-brain barrier. Horm Mol Biol Clin Investig. 2015;21:159–164.
42. Hagendorff A, Dettmers C, Danos P, et al. Myocardial and cerebral hemodynamics during tachyarrhythmia-induced hypotension in the rat. Circulation. 1994;90:400–410.
43. Kumar R, Yadav SK, Palomares JA, et al. Reduced regional brain cortical thickness in patients with heart failure. PLoS ONE. 2015;10:e0126595.
44. Molina F, Rus A, Peinado MA, Del Moral ML. Short-term hypoxia/reoxygenation activates the angiogenic pathway in rat caudate putamen. J Biosci. 2013;38:363–371.
45. Reaux-Le Goazigo A, Bodineau L, De Mota N, et al. Apelin and the proopiomelanocortin system: a new regulatory pathway of hypothalamic α-MSH release. Am J Physiol Endocrinol Metab 2011;301:E955–E966.
46. Hata J, Matsuda K, Ninomiya T, et al. Functional SNP in an Sp1-binding site of AGTRL1 gene is associated with susceptibility to brain infarction. Hum Mol Genet. 2007;16:630–639.
47. Kouzarides T. Chromatin modifications and their function. Cell. 2007;128:693–705.
48. Miranda TB, Jones PA. DNA methylation: the nuts and bolts of repression. J Cell Physiol. 2007;213:384–390.
49. Mishra A, Kohli S, Dua S, Thinlas T, Mohammad G, Pasha MA. Genetic differences and aberrant methylation in the apelin system predict the risk of high-altitude pulmonary edema. Proc Natl Acad Sci USA. 2015;112:6134–6139.
50. Pope GR, Roberts EM, Lolait SJ, O'Carroll AM. Central and peripheral apelin receptor distribution in the mouse: species differences with rat. Peptides. 2012;33:139–148.
51. Kleinz MJ, Baxter GF. Apelin reduces myocardial reperfusion injury independently of PI3K/Akt and P70S6 kinase. Regul Pept. 2008;146:271–277.
52. Koguchi W, Kobayashi N, Takeshima H, Ishikawa M, Sugiyama F, Ishimitsu T. Cardioprotective effect of apelin-13 on cardiac performance and remodeling in end-stage heart failure. Circ J. 2012;76:137–144.
53. Bertrand C, Valet P, Castan-Laurell I. Apelin and energy metabolism. Front Physiol. 2015;6:115.
54. Moon MK, Kim M, Chung SS, et al. S-Adenosyl-L-methionine ameliorates TNF alpha-induced insulin resistance in 3T3-L1 adipocytes. Exp Mol Med. 2010;42:345–352.
55. Selye H, Bajusz E, Grasso S, Mendell P. Simple techniques for the surgical occlusion of coronary vessels in the rat. Angiology. 1960;11:398–407.
56. Dobruch J, Cudnoch-Jedrzejewska A, Szczepanska-Sadowska E. Enhanced involvement of brain vasopressin V1 receptors in cardiovascular responses to stress in rats with myocardial infarction. Stress. 2005;8:273–284.
57. Pfeffer MA, Pfeffer JM, Fishbein MC, et al. Myocardial infarct size and ventricular function in rats. Circ Res. 1979;44:503–512.
58. Råmunddal T, Lorentzon M, Omerovic E. Decreased mortality in a rat model of acute postinfarction heart failure. Biochem Biophys Res Commun. 2006;341:459–463.
59. Kubota N, Terauchi Y, Miki H, et al. PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell. 1999;4:597–609.
60. Yamauchi T, Waki H, Kamon J, et al. Inhibition of RXR and PPAR gamma ameliorates diet-induced obesity and type 2 diabetes. J Clin Invest. 2001;108:1001–1013.